RDGT
Ridgetech Inc.
NASDAQ · Healthcare · Medical - Distribution · CN
$0.91
+0.77%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 252.1M | 132.2M | 120.0M | 154.5M | 148.8M |
| Cost of Revenue | 243.5M | 127.4M | 116.1M | 123.4M | 114.5M |
| Gross Profit | 8.6M | 4.8M | 3.8M | 31.1M | 34.3M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 11.5M | 6.6M | 4.9M | 34.6M | 55.2M |
| General & Admin Expense | 4.7M | 3.6M | 3.3M | 7.3M | 26.0M |
| Selling & Marketing Expense | 2.7M | 3.0M | 1.5M | 27.4M | 29.2M |
| Other Expenses | (148.6K) | — | — | — | — |
| Total Operating Expenses | 11.3M | 6.6M | 4.9M | 34.6M | 55.2M |
| Cost and Expenses | 254.9M | 134.0M | 121.0M | 158.1M | 169.7M |
| Operating Income (EBIT) | (2.8M) | (1.9M) | (1.0M) | (3.5M) | (20.9M) |
| Non-Operating | |||||
| Interest Income | 547.9K | 455.1K | 92.8K | 516.6K | 883.9K |
| Interest Expense | 67.1K | 67.1K | — | 13.6K | 65.9K |
| Net Interest Income | 480.8K | 388.0K | 92.8K | 503.0K | 818.1K |
| Other Non-Op Income/Expense | 452.6K | 516.5K | 84.7K | (636.8K) | 181.1K |
| Non-Operating Income (excl Interest) | 148.6K | — | — | 623.2K | (247.0K) |
| EBT (Pre-Tax Income) | (2.3M) | (1.3M) | (950.7K) | (4.2M) | (20.7M) |
| Income Tax Expense | 404.4K | (99.1K) | 503.5K | 62.9K | 394.5K |
| Bottom Line | |||||
| Net Income | 8.9M | (1.3M) | 10.2M | (4.2M) | (21.1M) |
| Earnings from Cont. Ops | (2.7M) | (1.3M) | (1.5M) | (4.2M) | (21.1M) |
| Earnings from Discont. Ops | 11.7M | — | 11.7M | — | — |
| Bottom Line Net Income | 8.9M | (1.3M) | 10.2M | (4.2M) | (21.1M) |
| Per Share | |||||
| Basic EPS | $9,562,266.91 | ($17.21) | $41,400.00 | ($65,925.00) | ($932,850.00) |
| Diluted EPS | $41,166.91 | ($17.21) | $41,400.00 | ($65,925.00) | ($932,850.00) |
| Revenue Per Share | $284.18 | $1,818.83 | $487,689.59 | $2,414,704.33 | $6,470,085.91 |
| Shares | |||||
| Basic Shares Outstanding | 887227 | 72664 | 246 | 64 | 23 |
| Diluted Shares Outstanding | 887227 | 72664 | 246 | 64 | 23 |
| Profitability Metrics | |||||
| EBITDA | 3.4M | (1.5M) | 5.0M | 1.2M | (20.0M) |
| D&A | 6.3M | 363.7K | 6.0M | 5.4M | 718.0K |
| EBIT | (2.9M) | (1.9M) | (1.0M) | (4.2M) | (20.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026